Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and 2023 Financial Guidance at 8 a.m. ET on February 8, 2023

Rhea-AI Summary

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will release its Q4 and full year 2022 financial results and 2023 financial guidance on February 8, 2023, at 7:00 a.m. ET. A conference call will follow at 8:00 a.m. ET. Interested participants can register here. A replay will be available within 24 hours on Teva's website.

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter and full year 2022 financial results, as well as on its financial guidance for 2023, on Wednesday, February 8, 2023 at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET.

In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin.

A live webcast of the call will be available on Teva's website at: https://ir.tevapharm.com/Events-and-Presentations

Following the conclusion of the call, a replay of the webcast will be available within 24 hours on Teva's website.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and innovative medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of innovative and biopharmaceutical products. Learn more at www.tevapharm.com.

Cautionary Note Regarding Forward-Looking Statements

This document and the conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace; our substantial indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in our Quarterly Report on Form 10-Q for the third quarter of 2022 and in our Annual Report on Form 10-K for the year ended December 31, 2021, including in the sections captioned “Risk Factors.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230112005201/en/

IR Contacts

Ran Meir (267) 468-4475

Yael Ashman +972 (3) 914 8262



PR Contacts

Kelley Dougherty (973) 832-2810

Eden Klein +972 (3) 906 2645

Source: Teva Pharmaceutical Industries Limited

FAQ

When will Teva Pharmaceuticals announce its Q4 2022 results?

Teva will announce its Q4 2022 results on February 8, 2023, at 7:00 a.m. ET.

What time is Teva's conference call regarding its financial results?

Teva's conference call will take place on February 8, 2023, at 8:00 a.m. ET.

How can I participate in Teva's financial results conference call?

You can register in advance for the call at the link provided in the press release.

Where can I find the live webcast of Teva's conference call?

The live webcast will be available on Teva's website at ir.tevapharm.com.

Is there a replay available for Teva's financial results call?

Yes, a replay of the call will be available within 24 hours on Teva's website.

What kind of information can I expect from Teva's financial results announcement?

You can expect insights on Q4 and full year 2022 financial performance, along with guidance for 2023.